Analyst Recommendations

Exane BNP Paribas analyst issues OUTPERFORM recommendation for SPSAF on May 30, 2024 04:36AM ET. SPSAF was trading at $238.27 at issue of the analyst recommendation.The overall analyst...

May 30, 2024   SPSAF -0.01%

Goldman Sachs analyst issues BUY recommendation for ISRG on May 30, 2024 04:32AM ET. ISRG was trading at $398.4 at issue of the analyst recommendation.The overall analyst consensus...

May 30, 2024   ISRG -0.69%

Goldman Sachs analyst issues NEUTRAL recommendation for SYK on May 30, 2024 04:31AM ET. SYK was trading at $341.14 at issue of the analyst recommendation.The overall analyst consensus...

May 30, 2024   SYK -0.91%

Goldman Sachs analyst issues SELL recommendation for RHHBY on May 30, 2024 04:32AM ET. RHHBY was trading at $31.33 at issue of the analyst recommendation.The overall analyst consensus...

May 30, 2024   RHHBY 0.01%

Goldman Sachs analyst issues NEUTRAL recommendation for GSK on May 30, 2024 04:34AM ET. GSK was trading at $44.28 at issue of the analyst recommendation.The overall analyst consensus...

May 30, 2024   GSK 1.45%

Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for SLVYY on May 30, 2024 04:39AM ET. SLVYY was trading at $3.65 at issue of the analyst recommendation.The overall analyst consensus...

May 30, 2024   SLVYY -1.53%

Goldman Sachs analyst issues SELL recommendation for SOLV on May 30, 2024 04:49AM ET. SOLV was trading at $59.72 at issue of the analyst recommendation.The overall analyst consensus...

May 30, 2024   SOLV 0.30%

Goldman Sachs analyst issues SELL recommendation for MDT on May 30, 2024 04:47AM ET. The previous analyst recommendation was Buy.MDT was trading at $81.49 at issue of the...

May 30, 2024   MDT -0.03%

Goldman Sachs analyst issues NEUTRAL recommendation for ZBH on May 30, 2024 04:48AM ET. ZBH was trading at $115.14 at issue of the analyst recommendation.The overall analyst consensus...

May 30, 2024   ZBH -0.12%

Goldman Sachs analyst issues NEUTRAL recommendation for BAX on May 30, 2024 04:51AM ET. The previous analyst recommendation was Buy.BAX was trading at $33.19 at issue of the...

May 30, 2024   BAX 0.46%